David Cheatham, OD
NPI 1467423210 · Optometrist · West Point, MS
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1467423210
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- OD
- Sex
- Male
- Sole proprietor
- No
- License
- 656 (MS)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,398 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 612 | $106 |
| Established Patient Complete Exam of Visual System92014 | 570 | $102 |
| Photography of the Retina92250 | 252 | $30 |
| Imaging of Optic Nerve92133 | 220 | $29 |
| Removal of Recurring Cataract in Lens Capsule Using a Laser66821 | 166 | $267 |
| Imaging of Retina92134 | 151 | $33 |
| Removal of Cataract With Insertion of Prosthetic Lens |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 32 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 527 | 159 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 196 | 60 |
| Prednisolone Acetate | 116 | 81 |
| Brimonidine Tartrate | 106 | 37 |
| Bimatoprostbrand: Lumigan | 106 | 37 |
| Dexamethasone Sodium Phosphate | 105 | 93 |
| Brimonidine Tartrate/Timololbrand: Combigan | 97 | 36 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$608 across 30 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-30
- Last updated
- 2010-07-08
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.